Healthcare -
Biotechnology - NASDAQ - US
$ 2.45
6.52 %
$ 170 M
Market Cap
-0.79
P/E
IKT - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities IKT - Inhibikase Therapeutics, Inc.
11.7 M
LAST VALUE
0.00%
2 YEAR CAGR
166.27%
5 YEAR CAGR
0.00%
10 YEAR CAGR